
Psychiatr News December 5, 2008
Volume 43, Number 23, page 16
© 2008 American Psychiatric Association
Some With Depression Able to Get Assisted Suicide
Rich Daly
Oregon's 11-year-old assisted-suicide law bars lethal prescriptions for
people found to have a mental disorder causing impaired judgment.
Although most terminally ill Oregonians who receive medical aid in dying
under the state's assisted-suicide law do not have depressive disorders, some
patients with depression did receive a prescription for a lethal drug,
researchers found.
The findings by Linda Ganzini, M.D., a professor of psychiatry at Oregon
Health and Science University, and her colleagues published October 27 in the
online version of BMJ (British Medical Journal) are the most recent
of several they have conducted on the state's assisted-suicide law.
The researchers examined 58 Oregonians, most terminally ill with cancer or
amyotrophic lateral sclerosis, who either had requested aid in dying from a
physician or contacted a right-to-die advocacy organization. A study
psychologist administered the Structured Clinical Interview for
DSM-IV Axis I Disorders (SCID-I). Then, a different psychologist
reviewed the auddiotapes, interspersed with interviews of terminal patients
not requesting aid in dying, and determined that 15 study participants met
criteria for depression and 13 met criteria for anxiety disorders.
Although thoughts of death or suicide and suicidal plans or attempts are
criteria for major depressive disorder in DSM, the researchers
attributed suicidal ideation to a diagnosis of depression only if the patient
endorsed suicidal thoughts or plans aside from their interest in pursuing
physician-assisted suicide.
By the end of the study, 42 patients had died. Among these, 18 had received
a prescription for a lethal drug, and nine had died by lethal ingestion of the
prescribed medication. Three lethal-dose recipients met the criteria for
depression and died by "legal ingestion," the study authors
found.
"Our findings also indicate that the current practice of legalized
aid in dying may allow some potentially ineligible patients to receive a
prescription for a lethal drug," said Ganzini and her coauthors.
The 11-year-old law authorizes physicians to prescribe a lethal dosage of
drugs—usually a short-acting barbiturate—to a competent adult who
requests it. Safeguards in the law aim to ensure that patients are adult,
competent, terminally ill, and choosing to end life voluntarily but not
impulsively.
Oregon's Death With Dignity Act requires the prescribing or consulting
physician to refer the requester of a fatal dose to a psychiatrist or
psychologist if he or she is concerned that the patient's judgment is impaired
by a mental disorder. The law bars prescribing a fatal dose until one of those
clinicians determines that the patient does not have a mental disorder causing
impaired judgment.
The recent research study comes as the debate continues over the influence
of psychiatric illness on an ill person's desire for assisted suicide.
"For people at the end of life, depression, hopelessness, and
psychosocial distress are among the strongest correlates of a desire for
hastened death," Ganzini and colleagues wrote.
Previous research has found that physicians, hospice professionals, and
family members of patients who seek assisted suicide in Oregon generally do
not believe that major depression was present in most patients who requested
assisted suicide. In fact, caretakers never requested psychiatric evaluations
for any of the people who died by assisted suicide in Oregon in 2007.
The authors pointed out that previous research has found that "health
care professionals" often fail to recognize depression and its impact,
particularly among medically ill patients.
A study conducted by Ganzini and colleagues and published in the September
2002 Journal of Pain and Symptom Management found that a feeling of
hopelessness—but not a major depressive disorder—at the start of
the study predicted a desire for assisted suicide later on. That ran counter
to research by William Breitbart, M.D., chief of the psychiatry service at
Memorial Sloan-Kettering Cancer Center. That study, published in the December
2000 JAMA, found that hopelessness and depression both contributed to
terminally ill patients' desire for a hastened death (Psychiatric
News, September 15, 2006).
Among the acknowledged limitations of the recent study was the inability to
understand the extent of the impact that depression, even when it had been
formally diagnosed, had on the patients' desire to end their lives. The
authors said that even the three depressed patients who died by lethal
ingestion could have satisfied the requirements of the Death With Dignity Act
if the attending physician had determined that depression was present but not
influencing their judgment.
"Although diagnosing depression can be relatively straightforward,
determining its role in influencing decision making is more difficult, even by
expert assessment," wrote Ganzini and colleagues.
A 1996 study published by Ganzini and colleagues in the American
Journal of Psychiatry, for example, found that among 321 psychiatrists in
Oregon, only 6 percent said they were very confident that a single evaluation
would allow them to adequately determine whether a psychiatric disorder was
impairing the judgment of a patient requesting assisted suicide.
The finding that some cases of depression in terminally ill patients
requesting physician-assisted suicide are missed or overlooked led the study
authors to conclude that the Oregon law may not adequately protect mentally
ill individuals. They urged "increased vigilance and systematic
examination for depression among patients who may access legalized aid in
dying."
Future research also is needed, Ganzini and colleagues noted, to help
determine the effect of treatment of depression on the choice to hasten
death.
An abstract of "Prevalence of Depression and Anxiety in
Patients Requesting Physicians' Aid in Dying: Cross-Sectional Survey" is
posted at
<www.bmj.com/cgi/content/abstract/337/oct07_2/a1682>.
Get information about faster international access.
a>
Privacy Policy
Copyright © 2008
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|